Abstract:Objective To evaluate the effectiveness, safety and operational performance of a domestically manufactured disposable endoscopic injection needle. Methods Patients with digestive tract lesions undergoing endoscopic surgery were selected from January 2024 to November 2024 in Endoscopy Center of Zhongshan Hospital (Xiamen), Fudan University and randomized to receive injections using either domestic (experimental group) or imported (control group) needles. Outcomes included injection success, safety events, and device maneuverability. Results A total of 200 patients were included, with 100 cases in each group. There were no significant differences in gender composition age, lesion size or the surgical procedures between the two groups (P>0.05). The single‑injection success rate was 88.0% (88/100) in experimental group versus 92.0% (92/100) for control group, with no significant difference (χ²=0.889, P=0.346). The safety outcomes showed no significant differences in injection‑induced hematomas [6.0% (6/100) VS 12.0% (12/100), χ²=2.198, P=0.138] or intraoperative bleeding [2.0% (2/100) VS 3.0% (3/100), P=1.000]. No clinically significant hematomas, postoperative bleeding, or perforations occurred in either group. Device malfunction rates were comparable, including needle insertion failure (1 case each), injection resistance (3 VS 2 cases), and latch slippage (none) (P=1.000). Conclusion Domestically produced disposable endoscopic injection needles demonstrate non‑inferior efficacy, safety, and operability compared with internationally branded counterparts in endoscopic resection procedures.